Speaker Profile

Ph.D., Director of Scientific Strategy and Business Development, Aiforia

Biography
Dr. Thomas Westerling-Bui received his PhD in cancer biology, focusing on the cell cycle and transcription, from the University of Helsinki Medical School in Finland. He completed a post-doctoral EMBO fellowship at the Dana Farber Cancer Institute in Boston, researching the genomics of breast and prostate cancer. Thomas joined Aiforia to advance the new potential of cancer biology, pathology, big data, and artificial intelligence.


AI and Data Sciences Showcase:
Aiforia

Aiforia equips pathologists and scientists with powerful deep learning artificial intelligence for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia software aims to escalate the efficiency and precision of preclinical and clinical medical image analysis from oncology to neuroscience and more.

Bringing Precision to Diagnostics with Deep Learning
Deep learning artificial intelligence enables increased speed, accuracy and consistency in medical image analysis. Aiforia's automated, AI-driven solutions supports pathologists in diagnosing some of the most prevalent cancers like breast and lung with greater efficiency and precision; paving the path for personalized therapy.

 Session Abstract – PMWC 2022 Silicon Valley


The PMWC 2022 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.